Blis MD review
Every peptide priced
A telehealth service that publishes a starting price for each peptide it sells — sermorelin, BPC-157, NAD⁺, CJC-1295 with ipamorelin, PT-141 and glutathione.
Our verdict
Blis MD publishes a per-molecule peptide price list, which almost nothing else on this board does, and it does it before you have handed over an email address. That is the case for it and it is a strong one. The case against is everything a price list cannot answer: no compounding pharmacy named, no medical director named, no states listed, no accreditation shown — and a menu that runs from a real mechanism straight into compounds with essentially no human evidence.
Disclosure: Aminoscope is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. This never affects our rankings or verdicts. How we make money.
At a glance
- Category
- Peptide telehealth
- Access
- NAD⁺ injections from $199/mo, free initial consult; state list not published
- Insurance
- Cash-pay, no insurance
- Visit
- Video visit
- Updated
- July 2026
Popular alternative
Oak Longevity
Low-cost sermorelin within a broader longevity stack
Check Oak Longevity availability →What it is
Blis MD is a US telehealth service offering GLP-1 weight-loss treatment alongside hormone therapy and a priced peptide line. Its pricing page lists starting monthly figures for sermorelin, BPC-157, NAD⁺ injections, CJC-1295 with ipamorelin, PT-141 and glutathione, each described as including a complimentary initial consultation and ongoing provider support. It publishes a phone number and an email address for support. It does not publish the states it serves or the pharmacy that compounds its products.
How it works
A free initial virtual consultation with a licensed provider gates the prescription, and the plans are described as including ongoing provider support and personalized protocols rather than a bare refill pipeline. A published phone number and email are a small thing that separates a practice from an anonymous storefront. What is missing is the verification layer: no compounding pharmacy is named, no medical director or clinical lead is named, no LegitScript or other accreditation is displayed, and no state list exists, so eligibility is only settled once you have booked. There is also no baseline lab work in the default path, which matters on a menu whose headline product acts on the growth-hormone axis. One practical note from our live check: the weight-loss figures on the same pricing page had moved since our earlier verification, so treat any published number as a snapshot and confirm it at intake.
Pricing transparency
Blis MD publishes sermorelin from $179/mo, which is the figure on our board, alongside NAD⁺ injections from $199/mo, CJC-1295 with ipamorelin from $199/mo, BPC-157 from $149/mo, PT-141 from $129/mo and glutathione from $99/mo. Every one carries a "starting at", and the site says actual cost varies with the individual treatment plan, so these are floors rather than quotes. Even so, a published floor per molecule is far more useful than the "pricing after application" posture most of this category takes — you can rank the menu by cost before speaking to anyone. Confirm what dose the starting figure supplies, what a titrated protocol costs, and whether shipping is extra.
Branded vs compounded
Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. The peptide and GLP-1 products are compounding-pharmacy preparations, not therapeutically equivalent to branded drugs, and no pharmacy is named — the clearest gap in an otherwise unusually open operation, because compounded sterile products are not FDA-reviewed for purity and potency the way approved drugs are. The menu needs reading by evidence tier rather than as one product class, and the price list flattens exactly that distinction. Sermorelin and the CJC-1295/ipamorelin pairing act on the growth-hormone axis: a real, well-described mechanism, with thin long-term human outcome data and no controlled trial supporting the body-composition or recovery claims. Injectable NAD⁺ has no controlled human outcome trials; the oral precursors NR and NMN are the studied forms and they demonstrate a raised blood NAD⁺ level rather than a clinical benefit. BPC-157 has essentially no controlled human outcome trials — its reputation rests on animal work and anecdote — and its availability through compounding pharmacies has moved with FDA decisions, so confirm what can actually be dispensed today. Injectable glutathione has essentially no controlled human outcome evidence either. Individual results vary.
Pros and watch-outs
What we like
- A starting price published for every peptide on the menu, before any intake
- Sermorelin from $179/mo, with the rest of the line priced alongside it for comparison
- Free initial virtual consultation with a licensed provider
- Plans described as including ongoing provider support and personalized protocols
- Phone number and support email published rather than a contact form only
Watch-outs
- Compounding pharmacy not named, and no LegitScript or other accreditation displayed
- No states listed — coverage is only confirmed once you book
- No named medical director or clinical lead
- All figures are "starting at", and the weight-loss prices had moved since our earlier check
- The price list puts BPC-157 and glutathione beside sermorelin as if the evidence were comparable
Best for
People who want to compare peptide costs molecule by molecule before booking anything, and who will do their own diligence on the pharmacy and prescriber.
Who should look elsewhere
Anyone who wants a named pharmacy, a named medical director, published state coverage, or lab-guided oversight before a growth-hormone-axis peptide.
The evidence behind what Blis MD prescribes
We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.
- Sermorelin: a real GHRH drug, read against the anti-aging pitch
An approved growth-hormone-releasing analog with a pediatric track record — and a longevity case built more on biomarkers than outcomes.
- NAD+ precursors (NR and NMN): what the human trials actually show
They raise NAD+ and look safe short-term — but human evidence is surrogate-marker level, and no trial shows they extend healthspan.
- BPC 157: what the evidence actually shows (and what it doesn't)
The 'healing peptide' has a deep rodent literature and almost no human data. A straight read of where the science stands.
How Blis MD compares
A few alternatives worth a look, depending on what you’re optimizing for.
- System Labs
NAD⁺ bundled with glutathione, B-12 and sermorelin from one service
See System Labs → 
Invigor MedicalPrescription at-home NAD⁺ injections via telehealth
See Invigor Medical →
Telos RXChoice of GLP-1 formats, including needle-free sublingual tirzepatide
See Telos RX →
Peptides & longevity · Reviewed and last verified July 2026
How we assessed this. This review reflects Aminoscope’s own read of Blis MD’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.
Frequently asked
- What does Blis MD charge for peptides?
- Its pricing page publishes sermorelin from $179/mo, NAD⁺ injections from $199/mo, CJC-1295 with ipamorelin from $199/mo, BPC-157 from $149/mo, PT-141 from $129/mo and glutathione from $99/mo, each with a complimentary initial consultation. All are "starting at" figures, and the site says the actual cost depends on your individual plan.
- Why is a published peptide price list unusual?
- Because most of this category quotes only after an application, which makes comparison shopping impossible and hands the pricing conversation to a salesperson. Publishing a floor per molecule lets you rank the whole menu before speaking to anyone. It does not tell you what a titrated protocol costs, so ask.
- Should I read the price list as a menu of equivalents?
- No. The molecules on it sit at very different evidence tiers. Sermorelin and CJC-1295/ipamorelin act on the growth-hormone axis — a real mechanism with thin outcome data. BPC-157 and injectable glutathione have essentially no controlled human outcome trials at all, and injected NAD⁺ has none either. A single price list makes them look comparable; the evidence does not.
- What does Blis MD not disclose?
- Its compounding pharmacy, its medical director, the states it serves, and any third-party accreditation. Those are the standard checks, and none can be completed from the site — which is the trade against its unusually open pricing.